Patents by Inventor Najing SU

Najing SU has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE INHIBITORS AND METHODS FOR USE OF THE SAME
    Publication number: 20230124268
    Abstract: Disclosed herein are compounds that can act as inhibitors of nicotinamide phosphoribosyltransferase (“NAMPT”), and methods for their use in treating or preventing diseases, such as pulmonary arterial hypertension (“PAH”). The compounds described herein can include compounds of Formula (II) and pharmaceutically acceptable salts thereof: wherein the substituents are as described.
    Type: Application
    Filed: November 16, 2022
    Publication date: April 20, 2023
    Inventors: Tom G. DRIVER, Roberto F. MACHADO, Najing SU, Xinyu GUAN, Wrickban MAZUMDAR, Kira RATIA, Jason Ralph HICKOK, Angelia Denise LOCKETT
  • Nicotinamide phosphoribosyltransferase inhibitors and methods for use of the same
    Patent number: 11584766
    Abstract: Disclosed herein are compounds that can act as inhibitors of nicotinamide phosphoribosyltransferase (“NAMPT”), and methods for their use in treating or preventing diseases, such as pulmonary arterial hypertension (“PAH”). The compounds described herein can include compounds of Formula (II) and pharmaceutically acceptable salts thereof: wherein the substituents are as described.
    Type: Grant
    Filed: February 5, 2019
    Date of Patent: February 21, 2023
    Assignees: THE TRUSTEES OF INDIANA UNIVERSITY, THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
    Inventors: Tom G. Driver, Roberto F. Machado, Najing Su, Xinyu Guan, Wrickban Mazumdar, Kira Ratia, Jason Ralph Hickok, Angelia Denise Lockett
  • NICOTINAMIDE PHOSPHORIBOSYLTRANSFERASE INHIBITORS AND METHODS FOR USE OF THE SAME
    Publication number: 20210070784
    Abstract: Disclosed herein are compounds that can act as inhibitors of nicotinamide phosphoribosyltransferase (“NAMPT”), and methods for their use in treating or preventing diseases, such as pulmonary arterial hypertension (“PAH”). The compounds described herein can include compounds of Formula (II) and pharmaceutically acceptable salts thereof: wherein the substituents are as described.
    Type: Application
    Filed: February 5, 2019
    Publication date: March 11, 2021
    Inventors: Tom G. DRIVER, Roberto F. MACHADO, Najing SU, Xinyu GUAN, Wrickban MAZUMDAR, Kira RATIA, Jason Ralph HICKOK, Angelia Denise LOCKETT